Post-stroke infection: a systematic review and meta-analysis

Willeke F Westendorp, Paul J Nederkoorn, Jan-Dirk Vermeij, Marcel G Dijkgraaf, Diederik van de Beek, Willeke F Westendorp, Paul J Nederkoorn, Jan-Dirk Vermeij, Marcel G Dijkgraaf, Diederik van de Beek

Abstract

Background: stroke is the main cause of disability in high-income countries, and ranks second as a cause of death worldwide. Patients with acute stroke are at risk for infections, but reported post-stroke infection rates vary considerably. We performed a systematic review and meta-analysis to estimate the pooled post-stroke infection rate and its effect on outcome.

Methods: MEDLINE and EMBASE were searched for studies on post-stroke infection. Cohort studies and randomized clinical trials were included when post-stroke infection rate was reported. Rates of infection were pooled after assessment of heterogeneity. Associations between population- and study characteristics and infection rates were quantified. Finally, we reviewed the association between infection and outcome.

Results: 87 studies were included involving 137817 patients. 8 studies were restricted to patients admitted on the intensive care unit (ICU). There was significant heterogeneity between studies (P < 0.001, I(2) = 97%). The overall pooled infection rate was 30% (24-36%); rates of pneumonia and urinary tract infection were 10% (95% confidence interval [CI] 9-10%) and 10% (95%CI 9-12%). For ICU studies, these rates were substantially higher with 45% (95% CI 38-52%), 28% (95%CI 18-38%) and 20% (95%CI 0-40%). Rates of pneumonia were higher in studies that specifically evaluated infections and in consecutive studies. Studies including older patients or more females reported higher rates of urinary tract infection. Pneumonia was significantly associated with death (odds ratio 3.62 (95%CI 2.80-4.68).

Conclusions: Infection complicated acute stroke in 30% of patients. Rates of pneumonia and urinary tract infection after stroke were 10%. Pneumonia was associated with death. Our study stresses the need to prevent infections in patients with stroke.

Figures

Figure 1
Figure 1
Flowchart of study selection.
Figure 2
Figure 2
Pooled odds ratios: effect of pneumonia on in-hospital mortality.

References

    1. Vermeij FH, Scholte op Reimer WJ, de Man MP, van Oostenbrugge RJ, Franke CL, de Jong G, de Kort PL, Dippel DW. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27:465–471. doi: 10.1159/000210093.
    1. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625.
    1. Nederkoorn PJ, Westendorp WF, Hooijenga IJ, de Haan RJ, Dippel DW, Vermeij FH, Dijkgraaf MG, Prins JM, Spanjaard L, van de Beek D. Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke. 2011;6:159–163. doi: 10.1111/j.1747-4949.2010.00555.x.
    1. Dziedzic T, Pera J, Klimkowicz A, Turaj W, Slowik A, Rog TM, Szczudlik A. Serum albumin level and nosocomial pneumonia in stroke patients. Eur J Neurol. 2006;13:299–301. doi: 10.1111/j.1468-1331.2006.01210.x.
    1. Dziedzic T, Slowik A, Pera J, Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007;252:53–56. doi: 10.1016/j.jns.2006.10.007.
    1. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588–600. doi: 10.1056/NEJMoa052980.
    1. Schwab S, Schwarz S, Bertram M, Spranger M, Hacke W. [Moderate hypothermia for the treatment of malignant middle cerebral artery infarct] Nervenarzt. 1999;70:539–546. doi: 10.1007/s001150050477.
    1. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, Mayer SA. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke. 2001;32:2033–2035. doi: 10.1161/hs0901.095394.
    1. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357:562–571. doi: 10.1056/NEJMoa070240.
    1. Newell SD, Englert J, Box-Taylor A, Davis KM, Koch KE. Clinical efficiency tools improve stroke management in a rural southern health system. Stroke. 1998;29:1092–1098. doi: 10.1161/01.STR.29.6.1092.
    1. Webb DJ, Fayad PB, Wilbur C, Thomas A, Brass LM. Effects of a specialized team on stroke care. The first two years of the Yale Stroke Program. Stroke. 1995;26:1353–1357. doi: 10.1161/01.STR.26.8.1353.
    1. van de Beek D, Wijdicks EF, Vermeij FH, de Haan RJ, Prins JM, Spanjaard L, Dippel DW, Nederkoorn PJ. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol. 2009;66:1076–1081. doi: 10.1001/archneurol.2009.176.
    1. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications After Acute Stroke. Stroke. 1996;27:415–420. doi: 10.1161/01.STR.27.3.415.
    1. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11:49–53. doi: 10.1046/j.1468-1331.2003.00749.x.
    1. Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, Gohler J, Bereswill S, Gobel U, Wolf T, Arnold G, Halle E, Volk HD, Dirnagl U, Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One. 2008;3:e2158. doi: 10.1371/journal.pone.0002158.
    1. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis. 2006;15:209–213. doi: 10.1016/j.jstrokecerebrovasdis.2006.05.004.
    1. Stott DJ, Falconer A, Miller H, Tilston JC, Langhorne P. Urinary tract infection after stroke. QJM. 2009;102:243–249. doi: 10.1093/qjmed/hcp012.
    1. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, Park JM, Bae HJ, Lee BC. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008;15:1324–1331. doi: 10.1111/j.1468-1331.2008.02310.x.
    1. Pinto AN, Melo TP, Lourenco ME, Leandro MJ, Brazio A, Carvalho L, Franco AS, Ferro JM. Can a clinical classification of stroke predict complications and treatments during hospitalization? Cerebrovasc Dis. 1998;8:204–209. doi: 10.1159/000015852.
    1. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008;7:341–353. doi: 10.1016/S1474-4422(08)70061-9.
    1. van der Kooi TI, Mannien J, Wille JC, van Benthem BH. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. J Hosp Infect. 2010;75:168–172. doi: 10.1016/j.jhin.2009.11.020.
    1. Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K. Aetiology of fever in patients with acute stroke. J Intern Med. 1999;246:203–209. doi: 10.1046/j.1365-2796.1999.00539.x.
    1. Hassan A, Khealani BA, Shafqat S, Aslam M, Salahuddin N, Syed NA, Baig SM, Wasay M. Stroke-associated pneumonia: microbiological data and outcome. Singapore Med J. 2006;47:204–207.
    1. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975–981. doi: 10.1161/.
    1. Gosney M, Martin MV, Wright AE. The role of selective decontamination of the digestive tract in acute stroke. Age Ageing. 2006;35:42–47. doi: 10.1093/ageing/afj019.
    1. Millns B, Gosney M, Jack CI, Martin MV, Wright AE. Acute stroke predisposes to oral gram-negative bacilli -- a cause of aspiration pneumonia? Gerontology. 2003;49:173–176. doi: 10.1159/000069171.
    1. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81–S87.
    1. Bartlett JG. Community-acquired pneumonia. Int J Clin Pract Suppl. 2000. pp. 18–22.
    1. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344:665–671. doi: 10.1056/NEJM200103013440908.
    1. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest. 1999;115:178–183. doi: 10.1378/chest.115.1.178.
    1. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. Formal dysphagia screening protocols prevent pneumonia. Stroke. 2005;36:1972–1976. doi: 10.1161/01.STR.0000177529.86868.8d.
    1. Kwon HM, Jeong SW, Lee SH, Yoon BW. The pneumonia score: a simple grading scale for prediction of pneumonia after acute stroke. Am J Infect Control. 2006;34:64–68. doi: 10.1016/j.ajic.2005.06.011.
    1. Adnet F, Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet. 1996;348:123–124.
    1. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36:2756–2763. doi: 10.1161/01.STR.0000190056.76543.eb.
    1. Walter U, Knoblich R, Steinhagen V, Donat M, Benecke R, Kloth A. Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol. 2007;254:1323–1329. doi: 10.1007/s00415-007-0520-0.
    1. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, Planas AM. Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry. 2006;77:1279–1281. doi: 10.1136/jnnp.2006.100800.
    1. Haeusler KG, Schmidt WU, Fohring F, Meisel C, Helms T, Jungehulsing GJ, Nolte CH, Schmolke K, Wegner B, Meisel A, Dirnagl U, Villringer A, Volk HD. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25:50–58.
    1. Emsley HC, Smith CJ, Hopkins SJ. Infection and brain-induced immunodepression after acute ischemic stroke. Stroke. 2008;39:e7. doi: 10.1161/STROKEAHA.107.500447.
    1. Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, Kessler C, Dressel A. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke. 2008;39:237–241. doi: 10.1161/STROKEAHA.107.493635.
    1. Spratt N, Wang Y, Levi C, Ng K, Evans M, Fisher J. A prospective study of predictors of prolonged hospital stay and disability after stroke. J Clin Neurosci. 2003;10:665–669. doi: 10.1016/j.jocn.2002.12.001.
    1. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796–808. doi: 10.1038/nm.2399.
    1. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–332. doi: 10.1016/j.ajic.2008.03.002.
    1. Kammersgaard LP, Jorgensen HS, Reith J, Nakayama H, Houth JG, Weber UJ. Early infection and prognosis after acute stroke: the Copenhagen Stroke Study. J Stroke Cerebrovasc Dis. 2001;10:217–221. doi: 10.1053/jscd.2001.30366.
    1. Yilmaz GR, Cevik MA, Erdinc FS, Ucler S, Tulek N. The risk factors for infections acquired by cerebral hemorrhage and cerebral infarct patients in a neurology intensive care unit in Turkey. Jpn J Infect Dis. 2007;60:87–91.
    1. Govan L, Langhorne P, Weir CJ. Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care?: further analysis of a systematic review. Stroke. 2007;38:2536–2540. doi: 10.1161/STROKEAHA.106.478842.
    1. Huang WY, Weng WC, Chien YY, Wu CL, Peng TI, Chen KH. Predictive factors of outcome and stroke recurrence in patients with unilateral atherosclerosis-related internal carotid artery occlusion. Neurol India. 2008;56:173–178. doi: 10.4103/0028-3886.41996.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner